Loxo Oncology, Inc
LOXO
LOXO was delisted on the 14th of February, 2019.
73 hedge funds and large institutions have $479M invested in Loxo Oncology, Inc in 2016 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 11 reducing their positions, and 6 closing their positions.
264% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 11
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
9% more funds holding
Funds holding: 67 → 73 (+6)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
5% less capital invested
Capital invested by funds: $504M → $479M (-$24.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.8M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$6.85M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.28M |
| 4 |
AC
Aisling Capital
New York
|
+$5.79M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
PointState Capital
New York
|
-$7.66M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
-$4.11M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$2.05M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.52M |
| 5 |
OPPM
Opus Point Partners Management
New York
|
-$984K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
76
BVF Inc
San Francisco,
California
| – | -$2.05M | -74,870 | Closed |
|
|
77
Invesco
Atlanta,
Georgia
| – | -$1.52M | -55,593 | Closed |
|
|
OPPM
78
Opus Point Partners Management
New York
| – | -$984K | -36,000 | Closed |
|
|
OAM
79
Oxford Asset Management
Oxford,
United Kingdom
| – | -$963K | -35,225 | Closed |
|
LOXO Hedge Fund Activity: Q2 2016 in Review
73 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q2 2016, worth a combined $479M — down 4.8% from $504M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new LOXO positions and 6 closed out — a net gain of 7 holders — while 40 added to existing stakes and 11 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $19.8M. The largest seller was PointState Capital, exiting entirely with an estimated $7.66M sold.
- 73 institutional investors held Loxo Oncology, Inc (LOXO) as of Q2 2016, up from 67 in Q1 2016.
- Funds reported $479M of Loxo Oncology, Inc stock for Q2 2016, down 4.8% quarter-over-quarter.
- 13 funds opened new Loxo Oncology, Inc positions in Q2 2016 and 6 closed out, a net change of +7 holders.
- The largest Loxo Oncology, Inc buyer in Q2 2016 was Wellington Management Group, an estimated $19.8M added.
- The largest Loxo Oncology, Inc seller in Q2 2016 was PointState Capital, an estimated $7.66M sold.
Based on aggregated 13F filings for Q2 2016.